Silverstein Eye Centers
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Employees
- 11
- Market Cap
- -
Omidria and Dexycu, or Omidria and Dextenza Compared to Topical Prednisolone Acetate 1% Following Cataract Surgery
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-03-20
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Silverstein Eye Centers
- Target Recruit Count
- 15
- Registration Number
- NCT04316936
- Locations
- 🇺🇸
Silverstein Eye Centers, Kansas City, Missouri, United States
Study Title: Clinical Outcomes of Prolensa (Bromfenac Ophthalmic Solution) 0.07% QD vs. Ilevro (Nepafenac Ophthalmic Suspension) 0.3% QD With Extra (Pulse) Dose on Day of Surgery for Treatment of Ocular Inflammation Associated With Cataract Surgery in a Randomized, Single Masked Clinical Trial
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-03-22
- Last Posted Date
- 2019-04-01
- Lead Sponsor
- Silverstein Eye Centers
- Target Recruit Count
- 57
- Registration Number
- NCT03886779
© Copyright 2024. All Rights Reserved by MedPath